Hofseth BioCare ASA
HBC
Rank in Stocks
#22777
Hofseth BioCare ASA, an international firm based in Norway, specializes in... Hofseth BioCare ASA, an international firm based in Norway, specializes in developing and supplying premium biomarine ingredients for both human and animal health. The company's product portfolio features various specialized offerings, including Brilliant salmon oil and OmeGo salmon oil, which promotes healthy cholesterol levels and supports cardiovascular well-being. ProGo, a salmon protein hydrolysate, serves as a rapidly assimilated protein supplement. For skeletal and joint health, Hofseth offers CalGo, a marine calcium powder. CollaGo, a collagen peptide powder, is designed to improve the appearance of hair, skin, and nails. Additionally, PetGo provides a non-soluble protein formulation. Distribution of these products is managed through a multi-channel approach, utilizing a network of distributors, agents, and its dedicated internal sales team. Hofseth BioCare also holds a significant research collaboration with Stanford University School of Medicine, focusing on pre-clinical and clinical studies related to conditions such as necrotizing enterocolitis and irritable bowel syndrome. Established in 2000, the company's main operations are based in Ålesund, Norway.
Share Price
$0.1212456
Last synced: 2026-11-09
Market Cap
$49.83M
Change (1 day)
4.28%
Change (1 year)
-31.48%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Hofseth BioCare ASA (HBC)
Category
Consumer Defensive
Operating Margin for Hofseth BioCare ASA (HBC)
Operating Margin as of November 2026 TTM: -48.27%
According to Hofseth BioCare ASA's latest financial reports, its current operating margin (TTM) is -48.27%. At the end of 2025 the company had an operating margin of -44.29%.
Operating Margin history for Hofseth BioCare ASA from 2010 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -48.27% | 8.99% |
| 2025 | -44.29% | 0.02% |
| 2024 | -44.28% | -15.83% |
| 2023 | -52.61% | -50.73% |
| 2022 | -106.78% | -21.09% |
| 2021 | -135.32% | 1.84% |
| 2020 | -132.88% | 13.19% |
| 2019 | -117.40% | -8.22% |
| 2018 | -127.92% | 1,253.65% |
| 2017 | -9.45% | -98.68% |
| 2016 | -715.52% | 322.63% |
| 2015 | -169.30% | -47.06% |
| 2014 | -319.78% | 323.83% |
| 2013 | -75.45% | -66.18% |
| 2012 | -223.12% | -89.15% |
| 2011 | -2,055.71% | -72.76% |
| 2010 | -7,546.78% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 14.06% | -100.29% |
CH
|
|
| 11.72% | -100.24% |
FR
|
|
| 5.67% | -100.12% |
BR
|
|
| 9.43% | -100.20% |
CN
|
|
| 26.85% | -100.56% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Hofseth BioCare ASA's operating margin
What is Hofseth BioCare ASA's operating margin?
Hofseth BioCare ASA's operating margin is -48.27%, as of Nov 2026.
What was Hofseth BioCare ASA's operating margin in 2025?
In 2025, Hofseth BioCare ASA's operating margin was -44.29%, compared with -44.28% in 2024.
How has Hofseth BioCare ASA's operating margin changed since 2020?
From 2020 to 2025, Hofseth BioCare ASA's operating margin was highest in 2024 (-44.28%) and lowest in 2021 (-135.32%).
How does Hofseth BioCare ASA's operating margin compare with similar companies?
Hofseth BioCare ASA's operating margin (-48.27%) is lower than that of all 5 similar companies listed above. The highest among them is Foshan Haitian Flavouring and Food Company Ltd., with 26.85%.